Table of Contents 1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered: Ranking by Long Acting Insulins Revenue 1.4 Market Analysis by Type 1.4.1 Global Long Acting Insulins Market Size Growth Rate by Type: 2020 VS 2026 1.4.2 Insulin Glargine 1.4.3 Insulin Determir 1.4.4 Insulin Degludec 1.4.5 Long Acting Animal Insulin 1.5 Market by Application 1.5.1 Global Long Acting Insulins Market Share by Application: 2020 VS 2026 1.5.2 Home Use 1.5.3 Medical Institutions 1.5.4 Others 1.6 Study Objectives 1.7 Years Considered 2 Global Growth Trends by Regions 2.1 Long Acting Insulins Market Perspective (2015-2026) 2.2 Long Acting Insulins Growth Trends by Regions 2.2.1 Long Acting Insulins Market Size by Regions: 2015 VS 2020 VS 2026 2.2.2 Long Acting Insulins Historic Market Share by Regions (2015-2020) 2.2.3 Long Acting Insulins Forecasted Market Size by Regions (2021-2026) 2.3 Industry Trends and Growth Strategy 2.3.1 Market Top Trends 2.3.2 Market Drivers 2.3.3 Market Challenges 2.3.4 Porter’s Five Forces Analysis 2.3.5 Long Acting Insulins Market Growth Strategy 2.3.6 Primary Interviews with Key Long Acting Insulins Players (Opinion Leaders) 3 Competition Landscape by Key Players 3.1 Global Top Long Acting Insulins Players by Market Size 3.1.1 Global Top Long Acting Insulins Players by Revenue (2015-2020) 3.1.2 Global Long Acting Insulins Revenue Market Share by Players (2015-2020) 3.1.3 Global Long Acting Insulins Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.2 Global Long Acting Insulins Market Concentration Ratio 3.2.1 Global Long Acting Insulins Market Concentration Ratio (CR5 and HHI) 3.2.2 Global Top 10 and Top 5 Companies by Long Acting Insulins Revenue in 2019 3.3 Long Acting Insulins Key Players Head office and Area Served 3.4 Key Players Long Acting Insulins Product Solution and Service 3.5 Date of Enter into Long Acting Insulins Market 3.6 Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type (2015-2026) 4.1 Global Long Acting Insulins Historic Market Size by Type (2015-2020) 4.2 Global Long Acting Insulins Forecasted Market Size by Type (2021-2026) 5 Long Acting Insulins Breakdown Data by Application (2015-2026) 5.1 Global Long Acting Insulins Market Size by Application (2015-2020) 5.2 Global Long Acting Insulins Forecasted Market Size by Application (2021-2026) 6 North America 6.1 North America Long Acting Insulins Market Size (2015-2020) 6.2 Long Acting Insulins Key Players in North America (2019-2020) 6.3 North America Long Acting Insulins Market Size by Type (2015-2020) 6.4 North America Long Acting Insulins Market Size by Application (2015-2020) 7 Europe 7.1 Europe Long Acting Insulins Market Size (2015-2020) 7.2 Long Acting Insulins Key Players in Europe (2019-2020) 7.3 Europe Long Acting Insulins Market Size by Type (2015-2020) 7.4 Europe Long Acting Insulins Market Size by Application (2015-2020) 8 China 8.1 China Long Acting Insulins Market Size (2015-2020) 8.2 Long Acting Insulins Key Players in China (2019-2020) 8.3 China Long Acting Insulins Market Size by Type (2015-2020) 8.4 China Long Acting Insulins Market Size by Application (2015-2020) 9 Japan 9.1 Japan Long Acting Insulins Market Size (2015-2020) 9.2 Long Acting Insulins Key Players in Japan (2019-2020) 9.3 Japan Long Acting Insulins Market Size by Type (2015-2020) 9.4 Japan Long Acting Insulins Market Size by Application (2015-2020) 10 Southeast Asia 10.1 Southeast Asia Long Acting Insulins Market Size (2015-2020) 10.2 Long Acting Insulins Key Players in Southeast Asia (2019-2020) 10.3 Southeast Asia Long Acting Insulins Market Size by Type (2015-2020) 10.4 Southeast Asia Long Acting Insulins Market Size by Application (2015-2020) 11 India 11.1 India Long Acting Insulins Market Size (2015-2020) 11.2 Long Acting Insulins Key Players in India (2019-2020) 11.3 India Long Acting Insulins Market Size by Type (2015-2020) 11.4 India Long Acting Insulins Market Size by Application (2015-2020) 12 Central & South America 12.1 Central & South America Long Acting Insulins Market Size (2015-2020) 12.2 Long Acting Insulins Key Players in Central & South America (2019-2020) 12.3 Central & South America Long Acting Insulins Market Size by Type (2015-2020) 12.4 Central & South America Long Acting Insulins Market Size by Application (2015-2020) 13Key Players Profiles 13.1 Novo Nordisk 13.1.1 Novo Nordisk Company Details 13.1.2 Novo Nordisk Business Overview and Its Total Revenue 13.1.3 Novo Nordisk Long Acting Insulins Introduction 13.1.4 Novo Nordisk Revenue in Long Acting Insulins Business (2015-2020)) 13.1.5 Novo Nordisk Recent Development 13.2 Sanofi 13.2.1 Sanofi Company Details 13.2.2 Sanofi Business Overview and Its Total Revenue 13.2.3 Sanofi Long Acting Insulins Introduction 13.2.4 Sanofi Revenue in Long Acting Insulins Business (2015-2020) 13.2.5 Sanofi Recent Development 13.3 Wockhardt UK 13.3.1 Wockhardt UK Company Details 13.3.2 Wockhardt UK Business Overview and Its Total Revenue 13.3.3 Wockhardt UK Long Acting Insulins Introduction 13.3.4 Wockhardt UK Revenue in Long Acting Insulins Business (2015-2020) 13.3.5 Wockhardt UK Recent Development 14Analyst's Viewpoints/Conclusions 15Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.2 Data Source 15.2 Disclaimer 15.3 Author Details

List of Tables Table 1. Long Acting Insulins Key Market Segments Table 2. Key Players Covered: Ranking by Long Acting Insulins Revenue Table 3. Ranking of Global Top Long Acting Insulins Manufacturers by Revenue (US$ Million) in 2019 Table 4. Global Long Acting Insulins Market Size Growth Rate by Type (US$ Million): 2020 VS 2026 Table 5. Key Players of Insulin Glargine Table 6. Key Players of Insulin Determir Table 7. Key Players of Insulin Degludec Table 8. Key Players of Long Acting Animal Insulin Table 9. Global Long Acting Insulins Market Size Growth by Application (US$ Million): 2020 VS 2026 Table 10. Global Long Acting Insulins Market Size by Regions (US$ Million): 2020 VS 2026 Table 11. Global Long Acting Insulins Market Size by Regions (2015-2020) (US$ Million) Table 12. Global Long Acting Insulins Market Share by Regions (2015-2020) Table 13. Global Long Acting Insulins Forecasted Market Size by Regions (2021-2026) (US$ Million) Table 14. Global Long Acting Insulins Market Share by Regions (2021-2026) Table 15. Market Top Trends Table 16. Key Drivers: Impact Analysis Table 17. Key Challenges Table 18. Long Acting Insulins Market Growth Strategy Table 19. Main Points Interviewed from Key Long Acting Insulins Players Table 20. Global Long Acting Insulins Revenue by Players (2015-2020) (Million US$) Table 21. Global Long Acting Insulins Market Share by Players (2015-2020) Table 22. Global Top Long Acting Insulins Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Long Acting Insulins as of 2019) Table 23. Global Long Acting Insulins by Players Market Concentration Ratio (CR5 and HHI) Table 24. Key Players Headquarters and Area Served Table 25. Key Players Long Acting Insulins Product Solution and Service Table 26. Date of Enter into Long Acting Insulins Market Table 27. Mergers & Acquisitions, Expansion Plans Table 28. Global Long Acting Insulins Market Size by Type (2015-2020) (Million US$) Table 29. Global Long Acting Insulins Market Size Share by Type (2015-2020) Table 30. Global Long Acting Insulins Revenue Market Share by Type (2021-2026) Table 31. Global Long Acting Insulins Market Size Share by Application (2015-2020) Table 32. Global Long Acting Insulins Market Size by Application (2015-2020) (Million US$) Table 33. Global Long Acting Insulins Market Size Share by Application (2021-2026) Table 34. North America Key Players Long Acting Insulins Revenue (2019-2020) (Million US$) Table 35. North America Key Players Long Acting Insulins Market Share (2019-2020) Table 36. North America Long Acting Insulins Market Size by Type (2015-2020) (Million US$) Table 37. North America Long Acting Insulins Market Share by Type (2015-2020) Table 38. North America Long Acting Insulins Market Size by Application (2015-2020) (Million US$) Table 39. North America Long Acting Insulins Market Share by Application (2015-2020) Table 40. Europe Key Players Long Acting Insulins Revenue (2019-2020) (Million US$) Table 41. Europe Key Players Long Acting Insulins Market Share (2019-2020) Table 42. Europe Long Acting Insulins Market Size by Type (2015-2020) (Million US$) Table 43. Europe Long Acting Insulins Market Share by Type (2015-2020) Table 44. Europe Long Acting Insulins Market Size by Application (2015-2020) (Million US$) Table 45. Europe Long Acting Insulins Market Share by Application (2015-2020) Table 46. China Key Players Long Acting Insulins Revenue (2019-2020) (Million US$) Table 47. China Key Players Long Acting Insulins Market Share (2019-2020) Table 48. China Long Acting Insulins Market Size by Type (2015-2020) (Million US$) Table 49. China Long Acting Insulins Market Share by Type (2015-2020) Table 50. China Long Acting Insulins Market Size by Application (2015-2020) (Million US$) Table 51. China Long Acting Insulins Market Share by Application (2015-2020) Table 52. Japan Key Players Long Acting Insulins Revenue (2019-2020) (Million US$) Table 53. Japan Key Players Long Acting Insulins Market Share (2019-2020) Table 54. Japan Long Acting Insulins Market Size by Type (2015-2020) (Million US$) Table 55. Japan Long Acting Insulins Market Share by Type (2015-2020) Table 56. Japan Long Acting Insulins Market Size by Application (2015-2020) (Million US$) Table 57. Japan Long Acting Insulins Market Share by Application (2015-2020) Table 58. Southeast Asia Key Players Long Acting Insulins Revenue (2019-2020) (Million US$) Table 59. Southeast Asia Key Players Long Acting Insulins Market Share (2019-2020) Table 60. Southeast Asia Long Acting Insulins Market Size by Type (2015-2020) (Million US$) Table 61. Southeast Asia Long Acting Insulins Market Share by Type (2015-2020) Table 62. Southeast Asia Long Acting Insulins Market Size by Application (2015-2020) (Million US$) Table 63. Southeast Asia Long Acting Insulins Market Share by Application (2015-2020) Table 64. India Key Players Long Acting Insulins Revenue (2019-2020) (Million US$) Table 65. India Key Players Long Acting Insulins Market Share (2019-2020) Table 66. India Long Acting Insulins Market Size by Type (2015-2020) (Million US$) Table 67. India Long Acting Insulins Market Share by Type (2015-2020) Table 68. India Long Acting Insulins Market Size by Application (2015-2020) (Million US$) Table 69. India Long Acting Insulins Market Share by Application (2015-2020) Table 70. Central & South America Key Players Long Acting Insulins Revenue (2019-2020) (Million US$) Table 71. Central & South America Key Players Long Acting Insulins Market Share (2019-2020) Table 72. Central & South America Long Acting Insulins Market Size by Type (2015-2020) (Million US$) Table 73. Central & South America Long Acting Insulins Market Share by Type (2015-2020) Table 74. Central & South America Long Acting Insulins Market Size by Application (2015-2020) (Million US$) Table 75. Central & South America Long Acting Insulins Market Share by Application (2015-2020) Table 76. Novo Nordisk Company Details Table 77. Novo Nordisk Business Overview Table 78. Novo Nordisk Product Table 79. Novo Nordisk Revenue in Long Acting Insulins Business (2015-2020) (Million US$) Table 80. Novo Nordisk Recent Development Table 81. Sanofi Company Details Table 82. Sanofi Business Overview Table 83. Sanofi Product Table 84. Sanofi Revenue in Long Acting Insulins Business (2015-2020) (Million US$) Table 85. Sanofi Recent Development Table 86. Wockhardt UK Company Details Table 87. Wockhardt UK Business Overview Table 88. Wockhardt UK Product Table 89. Wockhardt UK Revenue in Long Acting Insulins Business (2015-2020) (Million US$) Table 90. Wockhardt UK Recent Development Table 91. Research Programs/Design for This Report Table 92. Key Data Information from Secondary Sources Table 93. Key Data Information from Primary Sources List of Figures Figure 1. Global Long Acting Insulins Market Share by Type: 2020 VS 2026 Figure 2. Insulin Glargine Features Figure 3. Insulin Determir Features Figure 4. Insulin Degludec Features Figure 5. Long Acting Animal Insulin Features Figure 6. Global Long Acting Insulins Market Share by Application: 2020 VS 2026 Figure 7. Home Use Case Studies Figure 8. Medical Institutions Case Studies Figure 9. Others Case Studies Figure 10. Long Acting Insulins Report Years Considered Figure 11. Global Long Acting Insulins Market Size YoY Growth 2015-2026 (US$ Million) Figure 12. Global Long Acting Insulins Market Share by Regions: 2020 VS 2026 Figure 13. Global Long Acting Insulins Market Share by Regions (2021-2026) Figure 14. Porter's Five Forces Analysis Figure 15. Global Long Acting Insulins Market Share by Players in 2019 Figure 16. Global Top Long Acting Insulins Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Long Acting Insulins as of 2019 Figure 17. The Top 10 and 5 Players Market Share by Long Acting Insulins Revenue in 2019 Figure 18. North America Long Acting Insulins Market Size YoY Growth (2015-2020) (Million US$) Figure 19. Europe Long Acting Insulins Market Size YoY Growth (2015-2020) (Million US$) Figure 20. China Long Acting Insulins Market Size YoY Growth (2015-2020) (Million US$) Figure 21. Japan Long Acting Insulins Market Size YoY Growth (2015-2020) (Million US$) Figure 22. Southeast Asia Long Acting Insulins Market Size YoY Growth (2015-2020) (Million US$) Figure 23. India Long Acting Insulins Market Size YoY Growth (2015-2020) (Million US$) Figure 24. Central & South America Long Acting Insulins Market Size YoY Growth (2015-2020) (Million US$) Figure 25. Novo Nordisk Total Revenue (US$ Million): 2019 Compared with 2018 Figure 26. Novo Nordisk Revenue Growth Rate in Long Acting Insulins Business (2015-2020) Figure 27. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018 Figure 28. Sanofi Revenue Growth Rate in Long Acting Insulins Business (2015-2020) Figure 29. Wockhardt UK Total Revenue (US$ Million): 2019 Compared with 2018 Figure 30. Wockhardt UK Revenue Growth Rate in Long Acting Insulins Business (2015-2020) Figure 31. Bottom-up and Top-down Approaches for This Report Figure 32. Data Triangulation Figure 33. Key Executives Interviewed

Novo Nordisk Sanofi Wockhardt UK